Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jesse Galle"'
Autor:
Seyram A. Doe-Tetteh, Sabrina Y. Camp, Dalicia Reales, Jett Crowdis, Anne Marie Noronha, Bernadette Wolff, Tina Alano, Jesse Galle, S. Duygu Selcuklu, Agnes Viale, Nicholas D. Socci, Ying L. Liu, William P. Tew, Carol Aghajanian, Marc Ladanyi, Meng Xiao He, Saud H. AlDubayan, Roei David Mazor, Ofer Shpilberg, Oshrat Hershkovitz-Rokah, Jose A. Riancho, Jose L. Hernandez, M. Carmen Gonzalez-Vela, Justin J. Buthorn, Manda Wilson, Amy E. Webber, Mariko Yabe, Kseniya Petrova-Drus, Marc Rosenblum, Benjamin H. Durham, Omar Abdel-Wahab, Michael F. Berger, Mark T.A. Donoghue, Andrew L. Kung, Julia Glade Bender, Neerav N. Shukla, Samuel A. Funt, Ahmet Dogan, Robert A. Soslow, Hikmat Al-Ahmadie, Darren R. Feldman, Eliezer M. Van Allen, Eli L. Diamond, David B. Solit
Publikováno v:
Clinical Cancer Research. :OF1-OF11
Purpose: To overcome barriers to genomic testing for patients with rare cancers, we initiated a program to offer free clinical tumor genomic testing worldwide to patients with select rare cancer subtypes. Experimental Design: Patients were recruited
Autor:
David B. Solit, Eli L. Diamond, Eliezer M. Van Allen, Darren R. Feldman, Hikmat Al-Ahmadie, Robert A. Soslow, Ahmet Dogan, Samuel A. Funt, Neerav N. Shukla, Julia Glade Bender, Andrew L. Kung, Mark T.A. Donoghue, Michael F. Berger, Omar Abdel-Wahab, Benjamin H. Durham, Marc Rosenblum, Kseniya Petrova-Drus, Mariko Yabe, Amy E. Webber, Manda Wilson, Justin J. Buthorn, M. Carmen Gonzalez-Vela, Jose L. Hernandez, Jose A. Riancho, Oshrat Hershkovitz-Rokah, Ofer Shpilberg, Roei David Mazor, Saud H. AlDubayan, Meng Xiao He, Marc Ladanyi, Carol Aghajanian, William P. Tew, Ying L. Liu, Nicholas D. Socci, Agnes Viale, S. Duygu Selcuklu, Jesse Galle, Tina Alano, Bernadette Wolff, Anne Marie Noronha, Jett Crowdis, Dalicia Reales, Sabrina Y. Camp, Seyram A. Doe-Tetteh
Purpose:To overcome barriers to genomic testing for patients with rare cancers, we initiated a program to offer free clinical tumor genomic testing worldwide to patients with select rare cancer subtypes.Experimental Design:Patients were recruited thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777dd483d12e5edd5cb1b6e5d438e13a
https://doi.org/10.1158/1078-0432.c.6533084
https://doi.org/10.1158/1078-0432.c.6533084
Autor:
David B. Solit, Eli L. Diamond, Eliezer M. Van Allen, Darren R. Feldman, Hikmat Al-Ahmadie, Robert A. Soslow, Ahmet Dogan, Samuel A. Funt, Neerav N. Shukla, Julia Glade Bender, Andrew L. Kung, Mark T.A. Donoghue, Michael F. Berger, Omar Abdel-Wahab, Benjamin H. Durham, Marc Rosenblum, Kseniya Petrova-Drus, Mariko Yabe, Amy E. Webber, Manda Wilson, Justin J. Buthorn, M. Carmen Gonzalez-Vela, Jose L. Hernandez, Jose A. Riancho, Oshrat Hershkovitz-Rokah, Ofer Shpilberg, Roei David Mazor, Saud H. AlDubayan, Meng Xiao He, Marc Ladanyi, Carol Aghajanian, William P. Tew, Ying L. Liu, Nicholas D. Socci, Agnes Viale, S. Duygu Selcuklu, Jesse Galle, Tina Alano, Bernadette Wolff, Anne Marie Noronha, Jett Crowdis, Dalicia Reales, Sabrina Y. Camp, Seyram A. Doe-Tetteh
Genomically matched targeted therapies guided by MSK-IMPACT testing (n=22).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135e9ab78d66a7f3003e3661184c14d0
https://doi.org/10.1158/1078-0432.22490039
https://doi.org/10.1158/1078-0432.22490039
Autor:
David B. Solit, Eli L. Diamond, Eliezer M. Van Allen, Darren R. Feldman, Hikmat Al-Ahmadie, Robert A. Soslow, Ahmet Dogan, Samuel A. Funt, Neerav N. Shukla, Julia Glade Bender, Andrew L. Kung, Mark T.A. Donoghue, Michael F. Berger, Omar Abdel-Wahab, Benjamin H. Durham, Marc Rosenblum, Kseniya Petrova-Drus, Mariko Yabe, Amy E. Webber, Manda Wilson, Justin J. Buthorn, M. Carmen Gonzalez-Vela, Jose L. Hernandez, Jose A. Riancho, Oshrat Hershkovitz-Rokah, Ofer Shpilberg, Roei David Mazor, Saud H. AlDubayan, Meng Xiao He, Marc Ladanyi, Carol Aghajanian, William P. Tew, Ying L. Liu, Nicholas D. Socci, Agnes Viale, S. Duygu Selcuklu, Jesse Galle, Tina Alano, Bernadette Wolff, Anne Marie Noronha, Jett Crowdis, Dalicia Reales, Sabrina Y. Camp, Seyram A. Doe-Tetteh
Patient demographic data for the female patients in the Extragonadal GCT cohort (both Make-an-IMPACT and internal MSK patients, n=16)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b125f7239270c60829007f437e9ffcb
https://doi.org/10.1158/1078-0432.22490036
https://doi.org/10.1158/1078-0432.22490036
Autor:
David B. Solit, Eli L. Diamond, Eliezer M. Van Allen, Darren R. Feldman, Hikmat Al-Ahmadie, Robert A. Soslow, Ahmet Dogan, Samuel A. Funt, Neerav N. Shukla, Julia Glade Bender, Andrew L. Kung, Mark T.A. Donoghue, Michael F. Berger, Omar Abdel-Wahab, Benjamin H. Durham, Marc Rosenblum, Kseniya Petrova-Drus, Mariko Yabe, Amy E. Webber, Manda Wilson, Justin J. Buthorn, M. Carmen Gonzalez-Vela, Jose L. Hernandez, Jose A. Riancho, Oshrat Hershkovitz-Rokah, Ofer Shpilberg, Roei David Mazor, Saud H. AlDubayan, Meng Xiao He, Marc Ladanyi, Carol Aghajanian, William P. Tew, Ying L. Liu, Nicholas D. Socci, Agnes Viale, S. Duygu Selcuklu, Jesse Galle, Tina Alano, Bernadette Wolff, Anne Marie Noronha, Jett Crowdis, Dalicia Reales, Sabrina Y. Camp, Seyram A. Doe-Tetteh
Clonality assessment of known oncogenic mutations in the female GCT cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684d5fd9e50ce040a77fb8ed86c89160
https://doi.org/10.1158/1078-0432.22490045.v1
https://doi.org/10.1158/1078-0432.22490045.v1
Autor:
Marc Ladanyi, Gowtham Jayakumaran, Karen Cadoo, Ahmet Zehir, Philip Jonsson, Xiang Li, Jason Hwee, Meera Prasad, Michael Walsh, Jinru Shia, Allison Richards, Alexander V Penson, Aijazuddin Syed, Joseph Vijai, Roy Cambria, Michael F. Berger, Barry S. Taylor, Mark E. Robson, Semanti Mukherjee, Chaitanya Bandlamudi, Jianjiong Gao, Christopher J. Fong, Ozge Ceyhan-Birsoy, Maria I. Carlo, Liying Zhang, David M. Hyman, Preethi Srinivasan, Ino de Bruijn, Diana Mandelker, Jesse Galle, Selcuk Onur Sumer, Craig M. Bielski, Kenneth Offit, Shweta S. Chavan, Nikolaus Schultz, Yelena Kemel, David B. Solit, Zsofia K. Stadler
Publikováno v:
Nature genetics, vol 53, iss 11
Human cancers arise from environmental, heritable and somatic factors, but how these mechanisms interact in tumorigenesis is poorly understood. Studying 17,152 prospectively sequenced patients with cancer, we identified pathogenic germline variants i
Autor:
Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Mark Donoghue, Nikolaus Schultz, Debyani Chakravarty, Ritika Kundra, Ramyasree Madupuri, Yonina R. Murciano-Goroff, Hai-Yan Tu, Chong-Rui Xu, Andrés Martinez, Clare Wilhelm, Jesse Galle, Bobby Daly, Helena A. Yu, Michael Offin, Matthew D. Hellmann, Piro Lito, Kathryn C. Arbour, Marjorie G. Zauderer, Mark G. Kris, Kenneth K. Ng, Juliana Eng, Isabel Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Li, Candace Tong-Li, Madhawa De Silva, David L. Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian Lee, Natasha Rekhtman, Jason Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gonen, Valerie W. Rusch, Andreas Rimner, Daniel Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis-Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li
Publikováno v:
Nature medicine. 28(11)
Circulating tumor DNA (ctDNA) sequencing guides therapy decisions but has been studied mostly in small cohorts without sufficient follow-up to determine its influence on overall survival. We prospectively followed an international cohort of 1,127 pat
Autor:
J. Joshua Smith, Erin E. Salo-Mullen, Henry Walch, Diana Mandelker, Asha Krishnan, Michael F. Berger, Felix Steinruecke, Neil H. Segal, Gustavo Dos Santos Fernandes, Diane Reidy-Lagunes, Garrett M. Nash, Kimeisha Belanfanti, Leonard B. Saltz, Andrea Cercek, Zsofia K. Stadler, Karuna Ganesh, Anna M. Varghese, Chaitanya Bandlamudi, Mark E. Robson, Melissa Lumish, Jinru Shia, Vijai Joseph, Julio Garcia Aguilar, Nikolaus Schultz, Walid K. Chatila, Robin B. Mendelsohn, P. Paty, Kenneth Offit, Nancy E. Kemeny, Arnold J. Markowitz, Liying Zhang, Louise Catherine Connell, Preethi Srinivasan, Yelena Kemel, Barry S. Taylor, Ozge Birsoy, Jose G. Guillem, David B. Solit, Jesse Galle, Rona Yaeger, Sebastian Mondaca, Efsevia Vakiani, Luis A. Diaz, Anna Maio, Lerie Palmaira, Prince Rainier Tejada, Martin R. Weiser
Publikováno v:
J Natl Cancer Inst
Background The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is clinically or genomically distinct from average-onset colorectal cancer (AO-CRC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3723ce25fffa6cdb6d9d05fbf0a82091
https://europepmc.org/articles/PMC8634406/
https://europepmc.org/articles/PMC8634406/
Autor:
Marc Ladanyi, Michael Walsh, Anna M. Varghese, Ahmet Zehir, Erin E. Salo-Mullen, Kaitlyn Tkachuk, Nikolaus Schultz, Michael F. Berger, Wassim Abida, Bastien Nguyen, Shaleigh A. Smith, Margaret Sheehan, Diana Mandelker, Michael J. Morris, Christopher J. Fong, Maria I. Carlo, Carol Aghajanian, Gowtham Jayakumaran, Karen Cadoo, Anna Maio, Mark E. Robson, Nadeem R. Abu-Rustum, Amanda Erakky, Kenneth Offit, Luis A. Diaz, Alexander Drilon, Hongxin Zhang, Eileen M. O'Reilly, Zsofia K. Stadler, Debyani Chakravarty, Alicia Latham, Ozge Ceyhan-Birsoy, Ritika Kundra, David B. Solit, Yelena Kemel, Jesse Galle, Ying Liu
Publikováno v:
J Clin Oncol
PURPOSE Tumor mutational profiling is increasingly performed in patients with advanced cancer. We determined the extent to which germline mutation profiling guides therapy selection in patients with advanced cancer. METHODS Patients with cancer under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff91b5c9844b1c6c39c4ce2dbc82f20
https://europepmc.org/articles/PMC8376329/
https://europepmc.org/articles/PMC8376329/
Autor:
Margaret Sheehan, Maria I. Carlo, Mark E. Robson, Christina Tran, Chaitanya Bandlamudi, Yelena Y. Janjigian, Diana Mandelker, Karen Cadoo, Carolyn Stewart, Liying Zhang, Neil H. Segal, Michael F. Berger, Jaclyn F. Hechtman, Deborah DeLair, David M. Hyman, Anna M. Varghese, Julio Garcia Aguilar, José Baselga, David S. Klimstra, Kenneth Offit, Joseph Vijai, Jinru Shia, Martin R. Weiser, Marc Ladanyi, Dean F. Bajorin, Leonard B. Saltz, Diane Reidy-Lagunes, Michael Walsh, Semanti Mukherjee, Marianne Dubard-Gault, Mark A. Dickson, Luis A. Diaz, Barry S. Taylor, Sumit Middha, Ahmet Zehir, Eileen M. O'Reilly, Zsofia K. Stadler, Alicia Latham, Alexander V Penson, Preethi Srinivasan, Rona Yaeger, Yelena Kemel, Jesse Galle, David B. Solit
Publikováno v:
Journal of Clinical Oncology. 37:286-295
PURPOSE Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) testing has traditionally been performed in patients with colorectal (CRC) and endometrial cancer (EC) to screen for Lynch syndrome (LS)–associated cancer predisposi